Psychedelic Spotlight – Psychedelic Business Spotlight: July 30, 2021

MINDCURE recently launched the second stage of manufacturing pharmaceutical-grade ibogaine for clinical research purposes. The company is developing its ability to scale production, which involves rigorous testing to ensure that the compound is up to standard. The other assessment measures the company will use are timing and cost.

Access the article here.